Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Bicycle Therapeutics
company
About
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
- 101 - 250
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$161.90M
Bicycle Therapeutics has raised a total of
$161.90M
in funding over 2 rounds. Their latest funding was raised on
Oct 1, 2020 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2020 | Debt Financing | $50M | 1 | — | — | Detail |
| Dec 1, 2018 | Series B | $27.90M | 1 | — | — | Detail |
| Jun 1, 2017 | Series B | $52M | 1 | — | — | Detail |
| Oct 14, 2014 | Series A | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Bicycle Therapeutics is funded by 3 investors.
Hercules Capital
and Cambridge Innovation Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Hercules Capital
|
— | Debt Financing |
Cambridge Innovation Capital
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
